WHO INN Group Planning to Grapple with Biosimilar Names
Given the power of a name and the fact that more biosimilars are moving through the global pipeline, the World Health Organization (WHO) is facing increased pressure this week to come up with a new international nonproprietary naming (INN) scheme for the follow-on drugs.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter